BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8387074)

  • 1. Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line.
    Allen LE; Maher PA
    J Cell Physiol; 1993 May; 155(2):368-75. PubMed ID: 8387074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.
    Wieder R; Fenig E; Wang H; Wang Q; Paglin S; Menzel T; Gabrilove J; Fuks Z; Yahalom J
    J Cell Physiol; 1998 Dec; 177(3):411-25. PubMed ID: 9808150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines.
    New BA; Yeoman LC
    J Cell Physiol; 1992 Feb; 150(2):320-6. PubMed ID: 1310324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer.
    O'Brien T; Cranston D; Fuggle S; Bicknell R; Harris AL
    Cancer Res; 1997 Jan; 57(1):136-40. PubMed ID: 8988054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth.
    Gross JL; Morrison RS; Eidsvoog K; Herblin WF; Kornblith PL; Dexter DL
    J Neurosci Res; 1990 Dec; 27(4):689-96. PubMed ID: 1964181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling.
    Lee TH; Lee HC; Son YS; Kang MA; Park MJ; Nam MJ; Lee SH; Hong SI
    Endothelium; 2006; 13(3):191-203. PubMed ID: 16840175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
    Guo ZH; Mei H; Huang J; Li SY
    Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor enhanced LAK cell cytotoxicities against human bladder neoplasm cells.
    Wang ZP; Duan GL; Chen YR; Qin DS; Liu GD; Niu HG
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):276-8. PubMed ID: 10452107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo.
    Jouanneau J; Plouet J; Moens G; Thiery JP
    Oncogene; 1997 Feb; 14(6):671-6. PubMed ID: 9038374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines.
    Miyake H; Yoshimura K; Hara I; Eto H; Arakawa S; Kamidono S
    J Urol; 1997 Jun; 157(6):2351-5. PubMed ID: 9146669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.
    Gordon JN; Shu WP; Schlussel RN; Droller MJ; Liu BC
    Cancer Res; 1993 Oct; 53(20):4971-7. PubMed ID: 8402687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
    Rusnati M; Urbinati C; Presta M
    J Cell Physiol; 1993 Jan; 154(1):152-61. PubMed ID: 8419401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
    Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
    Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative characterization of high- and low-affinity binding sites for basic fibroblast growth factor on trabecular cells of the eye.
    Tripathi RC; Borisuth NS; Li J; Tripathi AJ; Tripathi BJ
    Exp Eye Res; 1997 Mar; 64(3):335-41. PubMed ID: 9196384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin and basic fibroblast growth factor regulate neurogenesis of murine embryonal carcinoma cells.
    Ameerun RF; de Winter JP; van den Eijnden-van Raaij AJ; den Hertog J; de Laat SW; Tertoolen LG
    Cell Growth Differ; 1996 Dec; 7(12):1679-88. PubMed ID: 8959336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
    Kondo Y; Hamada J; Kobayashi C; Nakamura R; Suzuki Y; Kimata R; Nishimura T; Kitagawa T; Kunimoto M; Imura N; Hara S
    J Urol; 2005 May; 173(5):1762-6. PubMed ID: 15821583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.